Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

290 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Coronary microevaginations characterize culprit plaques and their inflammatory microenvironment in a subtype of acute coronary syndrome with intact fibrous cap: results from the prospective translational OPTICO-ACS study.
Seppelt C, Abdelwahed YS, Meteva D, Nelles G, Stähli BE, Erbay A, Kränkel N, Sieronski L, Skurk C, Haghikia A, Sinning D, Dreger H, Knebel F, Trippel TD, Krisper M, Gerhardt T, Rai H, Klotsche J, Joner M, Landmesser U, Leistner DM. Seppelt C, et al. Among authors: rai h. Eur Heart J Cardiovasc Imaging. 2024 Jan 29;25(2):175-184. doi: 10.1093/ehjci/jead154. Eur Heart J Cardiovasc Imaging. 2024. PMID: 37395586
Patent foramen ovale closure versus medical therapy for prevention of recurrent cryptogenic embolism: updated meta-analysis of randomized clinical trials.
Alushi B, Lauten A, Cassese S, Colleran R, Schüpke S, Rai H, Schunkert H, Meier B, Landmesser U, Kastrati A. Alushi B, et al. Among authors: rai h. Clin Res Cardiol. 2018 Sep;107(9):788-798. doi: 10.1007/s00392-018-1246-y. Epub 2018 Apr 11. Clin Res Cardiol. 2018. PMID: 29644412 Free article. Review.
Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial.
Byrne RA, Alfonso F, Schneider S, Maeng M, Wiebe J, Kretov E, Bradaric C, Rai H, Cuesta J, Rivero F, Hoppmann P, Schlichtenmaier J, Christiansen EH, Cassese S, Joner M, Schunkert H, Laugwitz KL, Kastrati A. Byrne RA, et al. Among authors: rai h. Eur Heart J. 2019 Jan 7;40(2):167-176. doi: 10.1093/eurheartj/ehy710. Eur Heart J. 2019. PMID: 30520980 Clinical Trial.
Do outcomes following intervention for drug-eluting stent restenosis depend on whether the restenosed stent was polymer-free or polymer-coated?
Harada Y, Schneider S, Colleran R, Rai H, Bohner J, Kuna C, Kufner S, Giacoppo D, Schüpke S, Joner M, Ibrahim T, Laugwitz KL, Kastrati A, Byrne RA. Harada Y, et al. Among authors: rai h. Rev Esp Cardiol (Engl Ed). 2020 Mar;73(3):225-231. doi: 10.1016/j.rec.2019.01.005. Epub 2019 Mar 14. Rev Esp Cardiol (Engl Ed). 2020. PMID: 30878234 Clinical Trial. English, Spanish.
Optical Coherence Tomography Tissue Coverage and Characterization with Grey-Scale Signal Intensity Analysis After Bifurcation Stenting with a New Generation Bioabsorbable Polymer Drug-Eluting Stent.
Rai H, Hussein H, Colleran R, Xhepa E, Wiebe J, Pinieck S, Cassese S, Joner M, Kastrati A, Byrne RA, Foley DP. Rai H, et al. Cardiovasc Revasc Med. 2020 Mar;21(3):277-285. doi: 10.1016/j.carrev.2019.05.004. Epub 2019 May 8. Cardiovasc Revasc Med. 2020. PMID: 31155492
Outcomes after complete dissolution of everolimus-eluting bioresorbable scaffolds implanted during routine practice.
Wiebe J, Hoppmann P, Cassese S, Rheude T, Colleran R, Kuna C, Rai H, Valeskini M, Ibrahim T, Joner M, Schunkert H, Laugwitz KL, Kastrati A, Byrne RA. Wiebe J, et al. Among authors: rai h. Rev Esp Cardiol (Engl Ed). 2021 Jul;74(7):584-590. doi: 10.1016/j.rec.2020.07.005. Epub 2020 Aug 18. Rev Esp Cardiol (Engl Ed). 2021. PMID: 32819850 English, Spanish.
290 results